Fayetteville, Arkansas Clinical Trials

A listing of Fayetteville, Arkansas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

The reason for this study is to see if the study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer or endometrial cancer.

growth factors
metastasis
abemaciclib
stage iv breast cancer
human epidermal growth factor
Highlands Oncology Group
 (7.8 away) Contact site
  • 58 views
  • 22 Jul, 2021
  • +95 other locations
A Study to Determine the Safety Tolerability Pharmacokinetics and Preliminary Efficacy of ABBV-927 With ABBV-368 Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors

A study evaluating the safety, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of ABBV-927 with ABBV-368, Budigalimab (ABBV-181) and/or chemotherapy in participants with selected solid tumors. This study consists of 2 main parts, a dose-escalation phase and a dose-expansion phase. The dose-expansion phase can begin once the recommended phase 2 dose/maximum …

carboplatin
estrogen
primary cancer
adenocarcinoma
paclitaxel
Highlands Oncology Group /ID# 218863
 (6.3 away) Contact site
  • 52 views
  • 01 Aug, 2021
  • +37 other locations
Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma

Phase 1 open label, multi-center, dose-escalation study for individuals with relapsed or refractory B-cell Non Hodgkin's Lymphoma.

refractory b-cell non-hodgkin lymphoma
tg-1501
bendamustine
b-cell lymphoma
refractory classical hodgkin lymphoma
TG Therapeutics Investigational Trial Site
 (7.8 away) Contact site
  • 13 views
  • 28 Jul, 2021
  • +9 other locations
Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia

A Phase 1b Multi-cohort Study of TG-1801 Alone or in Combination with Ublituximab in Subjects with B-Cell Lymphoma or Chronic Lymphocytic Leukemia

lymphocytic leukemia
lymphoma
measurable disease
leukemia
monoclonal antibodies
TG Therapeutics Investigational Trial Site
 (1.2 away) Contact site
  • 0 views
  • 29 Jul, 2021
  • +5 other locations